Cancer and COVID-19 are both well-established risk factors predisposing to thrombosis.
Both disease entities are correlated with increased incidence of venous thrombotic events …

Abstract Introduction The Thoracic Centers International coronavirus disease 2019 (COVID-
19) Collaboration (TERAVOLT) registry found approximately 30% mortality in patients with …

Objective The impact of the coronavirus disease 2019 (COVID-19) pandemic on cancer care
remains a concern. We aimed to evaluate access to diagnosis and treatment for lung cancer …

Abstract Angiotensin-converting Enzyme 2 (ACE2) collaborates with Angiotensin (Ang) 1-7
and Mas receptors to establish the ACE2-Ang (1-7)-Mas receptor axis. ACE2 impacts lung …

COVID-19 pandemic generated concerns about the healthcare of patients with cancer, not
simply because of the formidable impact of COVID-19 patients in the public healthcare …

Clinical Practice Points• Patients with primary thoracic malignancies are at increased risk of
complications and death from COVID-19. Multiple studies have demonstrated humoral …

Background and aim Patients with interstitial lung diseases, including asbestosis, showed
high susceptibility to the SARS-CoV-2 virus and a high risk of severe COVID-19 symptoms …

Abstract Introduction Thymic epithelial tumors (TETs) are rare neoplasms often associated
with immune-related disorders. Patients with Good's syndrome (GS), an adult-acquired TET …

Background Patients with thoracic malignancies who develop COVID-19 infection have a
higher hospitalization rate compared to the general population and to those with other …

Clinical Practice Points• Patients with thoracic cancers and COVID-19 have high mortality
and morbidity.• Systematic data evaluating the impact of recent anti-cancer therapies on …